甲状腺癌微创甲状腺切除术的手术完整性与安全性:网络Meta分析
该网络Meta分析比较了9种微创或远程入路甲状腺切除术与常规甲状腺切除术在甲状腺癌患者中的手术结局。结果显示微创入路在住院时间、淋巴结清扫数目及手术完整性指标上与常规手术无显著差异,但机器人双侧腋乳入路和经口机器人甲状腺切除术手术时间较长。
要点
- 微创甲状腺切除术在手术完整性和安全性上不劣于常规甲状腺切除术。
- 机器人双侧腋乳入路和经口机器人甲状腺切除术手术时间显著更长。
- 需综合评估患者因素以选择合适的手术入路。
核心结论
- 微创甲状腺切除术相较于常规甲状腺切除术未显示劣势结局,尽管手术时间较长。
研究设计与样本
- 网络Meta分析,检索2020年1月至2022年7月6个数据库,纳入9种微创干预与常规甲状腺切除术对照的研究。
主要发现
- 微创干预与对照组在肿瘤多灶性、双侧性、淋巴结转移及甲状腺炎合并率上无显著差异。
- 对照组中观察到更大肿瘤尺寸(机器人双侧腋乳入路标准化均数差-1.3989,95%CI[-2.1717至-0.6262])。
- 对照组中观察到更高体重指数(机器人经腋窝入路标准化均数差-0.5350,95%CI[-0.9557至-0.1144];机器人双侧腋乳入路标准化均数差-0.2301,95%CI[-0.4389至-0.0214])。
- 对照组中观察到更频繁的甲状腺外侵犯(机器人双侧腋乳入路标准化均数差0.7435,95%CI[0.5602至0.9869])。
- 机器人双侧腋乳入路(标准化均数差6.5393,95%CI[5.0476至8.0309])和经口机器人甲状腺切除术(标准化均数差5.4946,95%CI[2.9984至7.9907])手术时间长于对照组。
关键数值与推荐
- 微创干预与对照组在住院时间或清扫淋巴结数目上无显著差异。
- 术后低血清甲状腺球蛋白率、术后甲状腺球蛋白水平及术后放射性碘消融剂量在微创干预与对照组间无显著差异。
临床怎么用
- 微创甲状腺切除术可作为甲状腺癌患者的可选术式,但需权衡较长手术时间。
- 选择手术入路时应审慎考虑患者各方面因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the surgical outcomes of various minimally invasive and remote-access surgical approaches for thyroid cancer patients. METHODS: We collected studies from January 2020 to July 2022 in 6 databases. Pairwise and network meta-analyses were performed for outcomes and complications of 9 minimally invasive interventions (minimally invasive video-assisted, endoscopic or robotic bilateral axillo-breast approach, endoscopic or robotic postauricular, endoscopic or robot transaxillary approach, transoral endoscopic thyroidectomy vestibular approach or robotic thyroidectomy) and conventional thyroidectomy (control). RESULTS: Multiplicity and bilaterality of cancer, lymph node metastasis, and coincidence of thyroiditis showed no significant difference between minimally invasive interventions and control. However, larger tumor size (robotic bilateral axillo-breast approach standardized mean difference -1.3989, 95% confidence interval [-2.1717 to -0.6262]), higher body mass index (robot transaxillary approach standardized mean difference -0.5350, 95% confidence interval [-0.9557 to -0.1144], robotic bilateral axillo-breast approach standardized mean difference -0.2301, 95% confidence interval [-0.4389 to -0.0214]), and frequent extrathyroidal extension (robotic bilateral axillo-breast approach standardized mean difference 0.7435, 95% confidence interval [0.5602-0.9869]) were observed in control. In surgical outcomes and adverse effects, there was no significant difference in hospitalization or retrieved lymph node number between minimally invasive interventions and control. However, longer operative time was observed in the robotic bilateral axillo-breast approach(standardized mean difference 6.5393, 95% confidence interval [5.0476-8.0309]) and transoral robotic thyroidectomy (standardized mean difference 5.4946, 95% confidence interval [2.9984-7.9907]) groups than in control. In surgical completion, the rate of low postoperative serum thyroglobulin, postoperative thyroglobulin level, and postoperative radioactive iodine ablation dose showed no significant difference between minimally invasive interventions and control. CONCLUSION: Minimally invasive thyroidectomy did not show inferior results compared to conventional thyroidectomy despite the longer operative time. Surgeons need to prudently consider all aspects of patients to determine the proper surgical approach for thyroid cancer.
引用
- Kang YJ, Stybayeva G, Hwang SH, et al. Surgical completeness and safety of minimally invasive thyroidectomy in patients with thyroid cancer: A network meta-analysis. Surgery. 2023. PMID: 36973129. doi:10.1016/j.surg.2023.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。